| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tubulin binding | KIF23 CENPE SYBU JMY TTLL7 CLIP3 SETD2 ALMS1 BRCA1 HOOK1 STARD9 CEP295 CAMSAP2 | 9.51e-05 | 428 | 173 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HIP1 KIF23 MYLK ANK2 CENPE SYBU SPATA32 JMY TTLL7 CLIP3 SETD2 ALMS1 BRCA1 HOOK1 PLEKHM2 STARD9 CEP295 EPS8L3 RFLNA MYO15A FERMT2 CAMSAP2 | 2.15e-04 | 1099 | 173 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.54e-04 | 70 | 173 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | microtubule binding | KIF23 CENPE SYBU JMY CLIP3 ALMS1 HOOK1 STARD9 CEP295 CAMSAP2 | 3.66e-04 | 308 | 173 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 3.97e-04 | 17 | 173 | 3 | GO:0001161 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.74e-04 | 118 | 173 | 6 | GO:0003774 | |
| GeneOntologyCellularComponent | chromosome, telomeric repeat region | 1.86e-04 | 14 | 172 | 3 | GO:0140445 | |
| GeneOntologyCellularComponent | t-UTP complex | 2.01e-04 | 3 | 172 | 2 | GO:0034455 | |
| Domain | Big_2 | 8.63e-05 | 2 | 174 | 2 | PF02368 | |
| Domain | Invasin/intimin_cell_adhesion | 8.63e-05 | 2 | 174 | 2 | IPR008964 | |
| Domain | BID_2 | 8.63e-05 | 2 | 174 | 2 | SM00635 | |
| Domain | Big_2 | 8.63e-05 | 2 | 174 | 2 | IPR003343 | |
| Domain | ALMS_motif | 2.57e-04 | 3 | 174 | 2 | IPR029299 | |
| Domain | ALMS_motif | 2.57e-04 | 3 | 174 | 2 | PF15309 | |
| Domain | POU_dom_5 | 2.57e-04 | 3 | 174 | 2 | IPR015585 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 16611995 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 38569549 | ||
| Pubmed | SYBU ANKHD1 NACAD RIF1 ALMS1 PLEKHM2 STARD9 CEP295 TNS3 ZNF292 | 3.63e-07 | 233 | 177 | 10 | 37704626 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 27494840 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 23333306 | ||
| Pubmed | The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells. | 5.16e-07 | 4 | 177 | 3 | 25331067 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 21295276 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 32075734 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 27373508 | ||
| Pubmed | A tight control of Rif1 by Oct4 and Smad3 is critical for mouse embryonic stem cell stability. | 5.16e-07 | 4 | 177 | 3 | 25569105 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ZNF609 MAK PDE9A COMT HEATR1 SSRP1 DTNBP1 EHD3 LRRC47 SCYL2 RIN1 NEK1 RIF1 HOOK1 KLHL7 SERINC1 NUP133 LAS1L FERMT2 USP15 CAMSAP2 RAVER1 | 1.12e-06 | 1321 | 177 | 22 | 27173435 |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 25761595 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 17991485 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 33894310 | ||
| Pubmed | Nanog, Oct4 and Tet1 interplay in establishing pluripotency. | 2.56e-06 | 6 | 177 | 3 | 27146218 | |
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 9171368 | ||
| Pubmed | 3.63e-06 | 21 | 177 | 4 | 28107452 | ||
| Pubmed | ZNF609 KIF23 RBM45 RBBP8 ZHX2 ZNF106 RIF1 SETD2 BRCA1 TINF2 ZBTB25 SMN1 | 4.01e-06 | 453 | 177 | 12 | 29656893 | |
| Pubmed | Mouse TEX14 is required for embryonic germ cell intercellular bridges but not female fertility. | 4.47e-06 | 7 | 177 | 3 | 19020301 | |
| Pubmed | Identification of Oct4-activating compounds that enhance reprogramming efficiency. | 4.47e-06 | 7 | 177 | 3 | 23213213 | |
| Pubmed | HMG box transcription factor gene Hbp1 is expressed in germ cells of the developing mouse testis. | 4.47e-06 | 7 | 177 | 3 | 15162515 | |
| Pubmed | The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. | 4.47e-06 | 7 | 177 | 3 | 16518401 | |
| Pubmed | 4.47e-06 | 7 | 177 | 3 | 11839785 | ||
| Pubmed | CHERP DSG2 NOL11 LRRC40 HEATR1 SSRP1 USP19 STAU1 LRRC47 SCYL2 RIF1 NUP210 NUP133 LAS1L | 5.49e-06 | 638 | 177 | 14 | 33239621 | |
| Pubmed | ZNF609 KIF23 GNL3L CHERP CENPE VPS13C BIRC6 STAU1 ZNF106 SETD2 ALMS1 CEP295 ESPL1 USP15 TNS3 | 5.82e-06 | 733 | 177 | 15 | 34672954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | KIF23 GNL3L CHERP ANK2 DSG1 DSG2 HEATR1 ANKHD1 STAU1 SCYL2 NEK1 RIF1 SETD2 ALMS1 NUP133 FERMT2 CAMSAP2 | 6.42e-06 | 934 | 177 | 17 | 33916271 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | HAUS3 SSRP1 DTNBP1 LRRC58 SCYL2 NEK1 SETD2 VAC14 ARAP3 PDE8B SIK2 SMN1 LAS1L FERMT2 ESPL1 CAMSAP2 ANAPC5 TNS3 | 6.57e-06 | 1038 | 177 | 18 | 26673895 |
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 29530881 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | GNL3L ANK2 DSG2 WWP1 ATP10D SLC38A1 FZD6 EFNB1 FERMT2 PLXNA1 PLXNA2 TNS3 GPRC5B | 7.82e-06 | 569 | 177 | 13 | 30639242 |
| Pubmed | WDR7 ZHX2 USP19 PCDHB16 FOCAD PLEKHM2 STARD9 PPIP5K1 USP15 CAMSAP2 PLXNA2 | 8.47e-06 | 407 | 177 | 11 | 12693553 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 1.04e-05 | 27 | 177 | 4 | 23395962 | |
| Pubmed | 1.06e-05 | 9 | 177 | 3 | 17138661 | ||
| Pubmed | 1.28e-05 | 100 | 177 | 6 | 24859004 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIF23 GNL3L CHERP DNAH10 DSG1 DSG2 VPS13C NOL11 LRRC40 HEATR1 SSRP1 ANKHD1 USP19 STAU1 LRRC47 SLC38A1 RIF1 STARD9 NUP210 NUP133 PLXNA1 | 1.30e-05 | 1425 | 177 | 21 | 30948266 |
| Pubmed | 1.51e-05 | 10 | 177 | 3 | 23521771 | ||
| Pubmed | Development of thyroid gland and ultimobranchial body cyst is independent of p63. | 1.51e-05 | 10 | 177 | 3 | 20697379 | |
| Pubmed | Cdk12 is essential for embryonic development and the maintenance of genomic stability. | 1.51e-05 | 10 | 177 | 3 | 26658019 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 SEMA7A FNTB WWP1 GRK6 AOC2 PEX6 ANKHD1 BIRC6 FOCAD PIAS4 JAK2 VAC14 ARAP3 PLEKHM2 NLE1 ESPL1 PLXNA1 | 1.52e-05 | 1105 | 177 | 18 | 35748872 |
| Pubmed | 1.60e-05 | 104 | 177 | 6 | 9205841 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | KIF23 SSRP1 STAU1 SETD2 NUP210 NUP133 SMN1 LAS1L ESPL1 USP15 ANAPC5 | 1.75e-05 | 440 | 177 | 11 | 34244565 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KIF23 GNL3L COMT DSG1 NOL11 LRRC40 HEATR1 SSRP1 ANKHD1 BIRC6 STAU1 LRRC47 RIN1 RIF1 ARAP3 NUP133 NLE1 LAS1L FERMT2 TNS3 | 2.03e-05 | 1353 | 177 | 20 | 29467282 |
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 31835801 | ||
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 16135792 | ||
| Pubmed | Nuclear reprogramming by interphase cytoplasm of two-cell mouse embryos. | 2.08e-05 | 11 | 177 | 3 | 24670652 | |
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 22167068 | ||
| Pubmed | Survival Motor Neuron Enhances Pluripotent Gene Expression and Facilitates Cell Reprogramming. | 2.08e-05 | 11 | 177 | 3 | 35848514 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 DSG1 NOL11 HAUS3 ANKHD1 STAU1 BRCA1 KLHL7 LAS1L FERMT2 ESPL1 TNS3 ZNF292 RAVER1 | 2.25e-05 | 724 | 177 | 14 | 36232890 |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23712259 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24594380 | ||
| Pubmed | PLXNA2 and LRRC40 as candidate genes in autism spectrum disorder. | 2.58e-05 | 2 | 177 | 2 | 33749153 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 2.58e-05 | 2 | 177 | 2 | 18932201 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21502535 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 33221301 | ||
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 2.58e-05 | 2 | 177 | 2 | 12641567 | |
| Pubmed | RIF1 counteracts BRCA1-mediated end resection during DNA repair. | 2.58e-05 | 2 | 177 | 2 | 23486525 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 2.58e-05 | 2 | 177 | 2 | 18765667 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 38139386 | ||
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 2.58e-05 | 2 | 177 | 2 | 18283123 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34463738 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34546511 | ||
| Pubmed | SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK. | 2.58e-05 | 2 | 177 | 2 | 35278271 | |
| Pubmed | Oct-4: more than just a POUerful marker of the mammalian germline? | 2.58e-05 | 2 | 177 | 2 | 9524569 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 25748933 | ||
| Pubmed | Expression pattern of Oct-4 in preimplantation embryos of different species. | 2.58e-05 | 2 | 177 | 2 | 11090438 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 32994224 | ||
| Pubmed | Networks of Transcription Factors for Oct4 Expression in Mice. | 2.58e-05 | 2 | 177 | 2 | 28731785 | |
| Pubmed | Oct-4 controls cell-cycle progression of embryonic stem cells. | 2.58e-05 | 2 | 177 | 2 | 19968627 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12702663 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 32850288 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26832419 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 22120493 | ||
| Pubmed | Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. | 2.58e-05 | 2 | 177 | 2 | 26435056 | |
| Pubmed | Characterization of a carboxy-terminal BRCA1 interacting protein. | 2.58e-05 | 2 | 177 | 2 | 9811458 | |
| Pubmed | Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. | 2.58e-05 | 2 | 177 | 2 | 9507072 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 36130732 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 9835353 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34788058 | ||
| Pubmed | Novel member of the mouse desmoglein gene family: Dsg1-beta. | 2.58e-05 | 2 | 177 | 2 | 12631242 | |
| Pubmed | Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. | 2.58e-05 | 2 | 177 | 2 | 17525163 | |
| Pubmed | Oct4 redox sensitivity potentiates reprogramming and differentiation. | 2.58e-05 | 2 | 177 | 2 | 38719541 | |
| Pubmed | A unique Oct4 interface is crucial for reprogramming to pluripotency. | 2.58e-05 | 2 | 177 | 2 | 23376973 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23580657 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 17932422 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 20083391 | ||
| Pubmed | Loss of Oct4 expression during the development of murine embryoid bodies. | 2.58e-05 | 2 | 177 | 2 | 22960235 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34068799 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 19190342 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11834739 | ||
| Pubmed | Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control. | 2.58e-05 | 2 | 177 | 2 | 19777066 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31843009 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18806757 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 37895112 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23325844 | ||
| Pubmed | [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer]. | 2.58e-05 | 2 | 177 | 2 | 25509123 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 1915274 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30653498 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21083502 | ||
| Pubmed | OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation. | 2.58e-05 | 2 | 177 | 2 | 27499297 | |
| Pubmed | Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. | 2.58e-05 | 2 | 177 | 2 | 11309664 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.31e-04 | 5 | 120 | 2 | 1336 | |
| GeneFamily | Phosphodiesterases | 5.21e-04 | 24 | 120 | 3 | 681 | |
| GeneFamily | Desmosomal cadherins | 8.98e-04 | 7 | 120 | 2 | 1188 | |
| GeneFamily | Plexins | 1.53e-03 | 9 | 120 | 2 | 683 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.00e-03 | 134 | 120 | 5 | 861 | |
| GeneFamily | Kelch like|BTB domain containing | 2.71e-03 | 42 | 120 | 3 | 617 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | DSG1 HBP1 BCL6 ATP10D ZNF106 TRANK1 SERINC1 PLAGL1 P2RY14 USP15 | 1.03e-06 | 199 | 176 | 10 | M5564 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | PDE9A CENPE HEATR1 ANKHD1 SLC38A1 NEK1 CLIP3 RIF1 SETD2 VAC14 USF3 ALMS1 BRCA1 HOOK1 PLEKHM2 PIK3CB NUP210 CEP295 IKBKB USP15 CDH2 ANAPC5 ZNF292 | 6.39e-06 | 989 | 174 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | PDE9A CENPE ANKHD1 NEK1 CLIP3 RIF1 USF3 ALMS1 BRCA1 CEP295 USP15 ZNF292 | 1.04e-05 | 311 | 174 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF23 CENPE RBBP8 WWP1 LRRC40 HAUS3 PPP1R15A CLIP3 RIF1 ALMS1 TET1 FERMT2 USP15 ZNF292 | 3.40e-05 | 469 | 174 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HIP1 KIF23 CENPE RBBP8 VPS13C WWP1 ZHX2 BIRC6 ZNF106 RIF1 ALMS1 BRCA1 HOOK1 FERMT2 CDH2 | 3.41e-05 | 532 | 174 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PDE9A CENPE ANKHD1 SCYL2 NEK1 CLIP3 RIF1 SETD2 ALMS1 BRCA1 HOOK1 NUP210 LRRC1 CEP295 IKBKB USP15 CDH2 ANAPC5 ZNF292 | 5.44e-05 | 831 | 174 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | SEMA7A DSG2 PPP1R15A ACVRL1 CFB TTLL7 EHD3 FZD6 LIFR ARAP3 FERMT2 PLXNA2 GPRC5B | 1.10e-04 | 459 | 174 | 13 | GSM777037_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SEMA7A CENPE RBM45 POU5F1 SYBU ANKHD1 BIRC6 RIF1 EFNB1 MAST4 BRCA1 HOOK1 LIPH TET1 CEP295 CPLANE1 CDH2 ANAPC5 | 1.16e-04 | 806 | 174 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KIF23 RBBP8 LRRC40 POU5F1 HEATR1 NEK1 RIF1 TRANK1 ALMS1 BRCA1 HOOK1 LIPH TET1 NUP210 NUP133 CEP295 CPLANE1 ESPL1 | 1.43e-04 | 820 | 174 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | KIF23 CENPE ZNF366 HLA-DQA1 BCL6 PPP1R15A JAK2 LIFR ALMS1 PIK3CB P2RY14 TNS3 | 1.47e-04 | 409 | 174 | 12 | GSM538234_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 1.73e-04 | 142 | 174 | 7 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.85e-04 | 101 | 174 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | CENPE RBM45 HLA-DQA1 HBP1 POU5F1 SYBU BIRC6 FOCAD RIF1 MAST4 HOOK1 TINF2 PDE8B TP63 TERB1 CEP295 CPLANE1 | 2.07e-04 | 770 | 174 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | KIF23 SEMA7A ZNF366 HLA-DQA1 BCL6 PPP1R15A ACVRL1 JAK2 ALMS1 PIK3CB P2RY14 TNS3 | 2.09e-04 | 425 | 174 | 12 | GSM538255_500 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 2.19e-04 | 196 | 174 | 8 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | KIF23 ANK2 DSG2 DOCK8 RBBP8 IGSF5 PPWD1 SCYL2 FZD6 HOOK1 PIK3CB LIPH TP63 SOCS4 LRRC1 GPRC5B ZNF292 | 2.40e-04 | 780 | 174 | 17 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.96e-04 | 259 | 174 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | NIPAL4 MYLK DOCK8 HLA-DQA1 IGSF5 BCL6 ADAM28 TTLL7 KLHL30 LIPH TP63 | 2.98e-04 | 378 | 174 | 11 | gudmap_developingLowerUrinaryTract_adult_bladder_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPE RBBP8 VPS13C PTPRU CLIP3 RIF1 ALMS1 BRCA1 HOOK1 STARD9 NUP210 LRRC1 PLAGL1 CREG2 CDH2 | 3.31e-04 | 654 | 174 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SEMA7A DSG2 HLA-DQA1 LRRC58 SLC22A17 SLC38A1 RIF1 TRANK1 BRCA1 HOOK1 PDE8B STARD9 LRRC1 NXF3 CDH2 PLXNA1 TNS3 GPRC5B | 3.39e-04 | 880 | 174 | 18 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | CENPE RBM45 POU5F1 SYBU BIRC6 RIF1 EFNB1 MAST4 HOOK1 LIPH TET1 SMN1 CEP295 CPLANE1 CDH2 ANAPC5 PLXNA2 | 3.41e-04 | 804 | 174 | 17 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 3.45e-04 | 159 | 174 | 7 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | MYLK BCL6 SCYL2 LIFR RTL3 KLHL30 SERINC1 TP63 SOCS4 PLAGL1 CPLANE1 FERMT2 CAMSAP2 PDE7B PLXNA2 GPRC5B ZNF292 | 3.51e-04 | 806 | 174 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | NIPAL4 MYLK DSG2 CENPE SPCS1 HEATR1 BIRC6 LIFR LIPH TP63 SOCS4 PLAGL1 ZNF770 CPLANE1 FERMT2 CDH2 PDE7B | 3.77e-04 | 811 | 174 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_200 | 3.82e-04 | 42 | 174 | 4 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k4_200 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | SEMA7A DSG2 PPP1R15A ACVRL1 CFB EHD3 FZD6 LIFR ARAP3 FERMT2 PLXNA2 GPRC5B | 3.96e-04 | 456 | 174 | 12 | GSM777032_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MYLK ANK2 DSG2 BIRC6 LIFR NEK1 KLHL30 TP63 PLAGL1 CPLANE1 FERMT2 CAMSAP2 CDH2 PDE7B ALK PLXNA2 GPRC5B | 4.15e-04 | 818 | 174 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 4.16e-04 | 164 | 174 | 7 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | KIF23 SEMA7A RBM45 HBP1 POU5F1 HEATR1 PIAS4 CLIP3 RIF1 EFNB1 BRCA1 HOOK1 LIPH NUP133 SMN1 ANAPC5 RAVER1 | 4.39e-04 | 822 | 174 | 17 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | KIF23 ZNF366 HLA-DQA1 LRRC40 TMEM107 BCL6 LIFR ALMS1 PIK3CB P2RY14 TNS3 | 4.50e-04 | 397 | 174 | 11 | GSM605827_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | POU5F1 HEATR1 RIF1 VAC14 BRCA1 HOOK1 PIK3CB LIPH TET1 NUP210 NUP133 ESPL1 | 4.53e-04 | 463 | 174 | 12 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | IGSF5 ZHX2 SLC22A17 PCDHB16 SLC38A1 CLIP3 CFAP54 RAVER2 CDH2 | 4.70e-04 | 276 | 174 | 9 | gudmap_kidney_P1_CapMes_Crym_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | HIP1 SEMA7A DOCK8 ZNF366 IRF2 POU5F1 PPP1R15A ACVRL1 PCDHB16 ATP10D FZD6 ARAP3 SACS PIK3CB STARD9 PLAGL1 PDE7B | 4.96e-04 | 831 | 174 | 17 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SEMA7A CENPE RBM45 POU5F1 BIRC6 RIF1 EFNB1 MAST4 LIPH TET1 CEP295 | 5.10e-04 | 403 | 174 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | POU5F1 HEATR1 RIF1 ALMS1 BRCA1 HOOK1 PIK3CB LIPH TET1 NUP133 ESPL1 | 5.42e-04 | 406 | 174 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_500 | 5.72e-04 | 82 | 174 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k2 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | KIF23 ZNF366 HLA-DQA1 LRRC40 TMEM107 BCL6 JAK2 ALMS1 PIK3CB P2RY14 TNS3 | 6.12e-04 | 412 | 174 | 11 | GSM538260_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | KIF23 CENPE ZNF366 HLA-DQA1 TMEM107 BCL6 ACVRL1 ALMS1 PIK3CB P2RY14 TNS3 | 6.12e-04 | 412 | 174 | 11 | GSM605828_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | RBM45 BIRC6 RIF1 EFNB1 MAST4 STARD9 TET1 CEP295 CPLANE1 CDH2 PLXNA2 | 6.25e-04 | 413 | 174 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 3.28e-08 | 173 | 177 | 9 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-08 | 190 | 177 | 9 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 152 | 177 | 8 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.03e-07 | 163 | 177 | 8 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 3.17e-07 | 164 | 177 | 8 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-07 | 164 | 177 | 8 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 4.56e-07 | 172 | 177 | 8 | 243b8bb01cbec5c1bf8802cbf8a6153356b4c384 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.28e-07 | 183 | 177 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.23e-07 | 186 | 177 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | VE-mDC1-|VE / Condition, Cell_class and T cell subcluster | 1.09e-06 | 193 | 177 | 8 | 5df6033bc0e4f96a20d526486a8e89c990e21831 | |
| ToppCell | MS-mDC1|MS / Condition, Cell_class and T cell subcluster | 1.09e-06 | 193 | 177 | 8 | 4d08ebf555954d6a873a4b4c4d661dc5dd8a5bcb | |
| ToppCell | MS-mDC1-|MS / Condition, Cell_class and T cell subcluster | 1.09e-06 | 193 | 177 | 8 | ce873f20b93e3b57c9385ee10d4becebe32ada06 | |
| ToppCell | VE-mDC1|VE / Condition, Cell_class and T cell subcluster | 1.09e-06 | 193 | 177 | 8 | 12b2708db9db8b88365b8ebeb4908f28c50081bb | |
| ToppCell | Monocytes-cDCs|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.27e-06 | 197 | 177 | 8 | 15cb9fe1c3bab80bd24728fd9ac7ba385912ac33 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 198 | 177 | 8 | 33690e16e4549b110e5b67f84b9515c696fe05e1 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.32e-06 | 198 | 177 | 8 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-06 | 200 | 177 | 8 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-06 | 200 | 177 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.42e-06 | 200 | 177 | 8 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, condition lineage and cell class | 1.42e-06 | 200 | 177 | 8 | cd381644fd8b8674a017d267bfbb00f2668294ae | |
| ToppCell | Sepsis-Int-URO-Myeloid-cDC1|Int-URO / Disease, condition lineage and cell class | 1.42e-06 | 200 | 177 | 8 | 77479f733cc4ce62a07ab33d5dc2d41c911c74fc | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, condition lineage and cell class | 1.42e-06 | 200 | 177 | 8 | 186852d54eced4c036876cc891773605068b56b5 | |
| ToppCell | Sepsis-URO-Myeloid-cDC1|URO / Disease, condition lineage and cell class | 1.42e-06 | 200 | 177 | 8 | c5ca81218be40b30e2f9252c1a004cb95d988447 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-06 | 148 | 177 | 7 | e44cdc1c3f3314c549a0afa9298c8568022b9d8b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-06 | 156 | 177 | 7 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 4.28e-06 | 164 | 177 | 7 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.46e-06 | 165 | 177 | 7 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 166 | 177 | 7 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.64e-06 | 166 | 177 | 7 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-06 | 167 | 177 | 7 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.64e-06 | 171 | 177 | 7 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 5.64e-06 | 171 | 177 | 7 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 173 | 177 | 7 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-06 | 173 | 177 | 7 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 6.56e-06 | 175 | 177 | 7 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 6.81e-06 | 176 | 177 | 7 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 6.81e-06 | 176 | 177 | 7 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.07e-06 | 177 | 177 | 7 | e68ad19963a3d8917dfdb81127a41c4fcbe61dd5 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-06 | 177 | 177 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-06 | 177 | 177 | 7 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-06 | 178 | 177 | 7 | dff7a59e53a7329212689ca234931ed4a1b67eee | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.61e-06 | 179 | 177 | 7 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.61e-06 | 179 | 177 | 7 | 9fc44637c9a7551fd47b8533e45a9c199e164a95 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-06 | 180 | 177 | 7 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 8.48e-06 | 182 | 177 | 7 | bb1f815718397de96682697fcbd6014a992a28f7 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 8.48e-06 | 182 | 177 | 7 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-06 | 182 | 177 | 7 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.79e-06 | 183 | 177 | 7 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 9.10e-06 | 184 | 177 | 7 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 9.10e-06 | 184 | 177 | 7 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 9.43e-06 | 185 | 177 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.43e-06 | 185 | 177 | 7 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 186 | 177 | 7 | 305f1726b8b5add32f1c29c74991ff34f42e0da7 | |
| ToppCell | normal_Lung-Myeloid_cells-CD141+_DCs|normal_Lung / Location, Cell class and cell subclass | 9.77e-06 | 186 | 177 | 7 | a6698a2f4edd81b67e06531ede0e207dd0309205 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 9.77e-06 | 186 | 177 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.77e-06 | 186 | 177 | 7 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 1.01e-05 | 187 | 177 | 7 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | (7)_DC_1|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.05e-05 | 188 | 177 | 7 | 832887afa4a54ed80906bc02176d646529c13398 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-05 | 188 | 177 | 7 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-05 | 188 | 177 | 7 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-05 | 188 | 177 | 7 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 1.05e-05 | 188 | 177 | 7 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 73 | 177 | 5 | 51bcbb57ee6c45cad88cb3e2cedab2cf3503b2a5 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 189 | 177 | 7 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-05 | 190 | 177 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-05 | 190 | 177 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.16e-05 | 191 | 177 | 7 | c3ff4342e0eea1e1f071b1fbca14a6dd4df0c696 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.20e-05 | 192 | 177 | 7 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.24e-05 | 193 | 177 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 193 | 177 | 7 | a260d943e9db966e4ce7d642313fd11354c2d2ba | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 194 | 177 | 7 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-05 | 194 | 177 | 7 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 194 | 177 | 7 | 2b5eee7c3e52b63cce94205d18133c7704329c02 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 194 | 177 | 7 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 195 | 177 | 7 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 1.33e-05 | 195 | 177 | 7 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 195 | 177 | 7 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 196 | 177 | 7 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-05 | 196 | 177 | 7 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.37e-05 | 196 | 177 | 7 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 196 | 177 | 7 | 4b9eb163b9dbbf5eebb160f6554f6f28cb234d31 | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-05 | 196 | 177 | 7 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 198 | 177 | 7 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-05 | 199 | 177 | 7 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, condition lineage and cell class | 1.51e-05 | 199 | 177 | 7 | 7f6569de050262f3d8d9d41c0f0cc139de85c0cb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | control-cDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 177 | 7 | 4a6d17a4225be38537d3dd8a39512051f597f4e0 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Control-Control-Myeloid-cDC1|Control / Disease, condition lineage and cell class | 1.56e-05 | 200 | 177 | 7 | 86db36c9f9316bfa4d8fa26c5a8239fd2d7d34c2 | |
| ToppCell | mild-cDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 177 | 7 | d6409ee5b9067be3dd2f852825e09151b5b22d7c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 142 | 177 | 6 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | ASK452-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-05 | 85 | 177 | 5 | 523a532e91aa271faab67d0256919b67af2bd7d8 | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 147 | 177 | 6 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.80e-05 | 156 | 177 | 6 | 03f3c5ffb27758fe63797143fcc938f9e8a4e10d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 4.08e-05 | 158 | 177 | 6 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | COVID-19-APC-like-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 4.08e-05 | 158 | 177 | 6 | a0d94bd067424783863a48db20976d4c2043600c | |
| Computational | Cancer module 320: M phase. | 3.98e-05 | 20 | 107 | 4 | MODULE_320 | |
| Disease | liver cancer (is_marker_for) | 1.62e-05 | 9 | 173 | 3 | DOID:3571 (is_marker_for) | |
| Disease | membranous glomerulonephritis (is_implicated_in) | 1.02e-04 | 3 | 173 | 2 | DOID:10976 (is_implicated_in) | |
| Disease | Arteritis | 1.02e-04 | 3 | 173 | 2 | C0003860 | |
| Disease | eosinophil count | CHERP FNTB RBBP8 HLA-DQA1 ABCB5 OAS2 BCL6 NACAD EHD3 SLC38A1 JAK2 SETD2 BRCA1 PDE8B RAVER2 NUP133 SIK2 PLAGL1 P2RY14 USP15 ZNF292 | 1.78e-04 | 1488 | 173 | 21 | EFO_0004842 |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.97e-04 | 49 | 173 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Fc receptor-like protein 4 measurement | 2.03e-04 | 4 | 173 | 2 | EFO_0801599 | |
| Disease | Fc receptor-like protein 3 measurement | 2.03e-04 | 4 | 173 | 2 | EFO_0008127 | |
| Disease | breast cancer (is_implicated_in) | 2.65e-04 | 150 | 173 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | ANK2 ABCB5 PTPRU ERI2 LRRC47 LIFR ARAP3 SACS TP63 P2RY14 LAS1L CAMSAP2 ZNF292 | 2.72e-04 | 702 | 173 | 13 | C0009402 |
| Disease | Prostatic Neoplasms | COMT PON1 IGSF5 ADAM28 JAK2 LIFR SETD2 BRCA1 PIK3CB EPS8L3 FGFR4 ZNF292 | 2.97e-04 | 616 | 173 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | COMT PON1 IGSF5 ADAM28 JAK2 LIFR SETD2 BRCA1 PIK3CB EPS8L3 FGFR4 ZNF292 | 2.97e-04 | 616 | 173 | 12 | C0376358 |
| Disease | liver cancer (is_implicated_in) | 3.38e-04 | 5 | 173 | 2 | DOID:3571 (is_implicated_in) | |
| Disease | thrombophilia (is_implicated_in) | 5.05e-04 | 6 | 173 | 2 | DOID:2452 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ANK2 COMT ZNF366 RIF1 SETD2 FCRL3 ARAP3 BRCA1 HOOK1 PIK3CB NUP133 NLE1 IKBKB CDH2 ANAPC5 ALK | 6.13e-04 | 1074 | 173 | 16 | C0006142 |
| Disease | prostate cancer (is_implicated_in) | 6.45e-04 | 117 | 173 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Glomerulonephritis, Membranoproliferative | 7.04e-04 | 7 | 173 | 2 | C0017662 | |
| Disease | survival time, coronary artery disease | 7.16e-04 | 30 | 173 | 3 | EFO_0000714, EFO_0001645 | |
| Disease | stomach cancer (is_implicated_in) | 8.61e-04 | 72 | 173 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | HMG CoA reductase inhibitor use measurement | 8.99e-04 | 189 | 173 | 6 | EFO_0009932 | |
| Disease | glucose intolerance (is_implicated_in) | 9.35e-04 | 8 | 173 | 2 | DOID:10603 (is_implicated_in) | |
| Disease | Henoch-Schoenlein purpura (is_implicated_in) | 9.35e-04 | 8 | 173 | 2 | DOID:11123 (is_implicated_in) | |
| Disease | antiphospholipid syndrome (is_implicated_in) | 9.35e-04 | 8 | 173 | 2 | DOID:2988 (is_implicated_in) | |
| Disease | psoriasis (is_implicated_in) | 1.04e-03 | 34 | 173 | 3 | DOID:8893 (is_implicated_in) | |
| Disease | Metabolic Diseases | 1.49e-03 | 10 | 173 | 2 | C0025517 | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 1.49e-03 | 10 | 173 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | thrombosis (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | transmembrane glycoprotein NMB measurement | 1.49e-03 | 10 | 173 | 2 | EFO_0008303 | |
| Disease | stomach cancer (is_marker_for) | 1.53e-03 | 142 | 173 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Hypercholesterolemia | 1.55e-03 | 39 | 173 | 3 | C0020443 | |
| Disease | beta thalassemia (is_marker_for) | 1.82e-03 | 11 | 173 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Behavior Disorders | 2.17e-03 | 12 | 173 | 2 | C0004930 | |
| Disease | Mental disorders | 2.17e-03 | 12 | 173 | 2 | C0004936 | |
| Disease | Hematologic Neoplasms | 2.17e-03 | 12 | 173 | 2 | C0376545 | |
| Disease | Mental Disorders, Severe | 2.17e-03 | 12 | 173 | 2 | C4046029 | |
| Disease | Thromboembolism | 2.17e-03 | 12 | 173 | 2 | C0040038 | |
| Disease | Diagnosis, Psychiatric | 2.17e-03 | 12 | 173 | 2 | C0376338 | |
| Disease | heart rate | 2.18e-03 | 225 | 173 | 6 | EFO_0004326 | |
| Disease | hip geometry | 2.20e-03 | 44 | 173 | 3 | EFO_0004685 | |
| Disease | Schizophrenia | COMT PRSS16 GRK6 PON1 DTNBP1 TEKT5 LIFR BRCA1 PIK3CB TET1 PDE7B ALK PLXNA2 | 2.20e-03 | 883 | 173 | 13 | C0036341 |
| Disease | Neurodevelopmental Disorders | 2.22e-03 | 93 | 173 | 4 | C1535926 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 2.35e-03 | 45 | 173 | 3 | EFO_0803319 | |
| Disease | selective IgA deficiency disease | 2.50e-03 | 46 | 173 | 3 | EFO_1001929 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Benign tumor of pancreas | 2.55e-03 | 13 | 173 | 2 | C0347284 | |
| Disease | N-acetylglutamine measurement | 2.55e-03 | 13 | 173 | 2 | EFO_0800017 | |
| Disease | Adenoid Cystic Carcinoma | 2.89e-03 | 100 | 173 | 4 | C0010606 | |
| Disease | sickle cell anemia (is_marker_for) | 2.97e-03 | 14 | 173 | 2 | DOID:10923 (is_marker_for) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.03e-03 | 166 | 173 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.19e-03 | 243 | 173 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | BMI-adjusted adiponectin measurement | 3.41e-03 | 15 | 173 | 2 | EFO_0007737 | |
| Disease | Rhabdomyosarcoma | 3.41e-03 | 15 | 173 | 2 | C0035412 | |
| Disease | thrombosis (is_implicated_in) | 3.41e-03 | 15 | 173 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | diet measurement | PRSS16 NUP210L HLA-DQA1 GRK6 IL20RB SLC22A17 DNAH14 PCDHB16 SCYL2 SLC38A1 NEK1 TRANK1 SIK2 ZNF770 | 3.65e-03 | 1049 | 173 | 14 | EFO_0008111 |
| Disease | focal segmental glomerulosclerosis | 3.89e-03 | 16 | 173 | 2 | EFO_0004236 | |
| Disease | Dermatitis | 3.89e-03 | 16 | 173 | 2 | C0011603 | |
| Disease | granulocyte count | 3.96e-03 | 254 | 173 | 6 | EFO_0007987 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.07e-03 | 110 | 173 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.07e-03 | 110 | 173 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.16e-03 | 55 | 173 | 3 | C0079744 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 4.16e-03 | 55 | 173 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.20e-03 | 111 | 173 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | anti-anoctamin 2 antibody measurement | 4.39e-03 | 17 | 173 | 2 | EFO_0010150 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.39e-03 | 17 | 173 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | alcohol dependence | 4.58e-03 | 183 | 173 | 5 | MONDO_0007079 | |
| Disease | coronary artery disease | DNAH10 DOCK8 HLA-DQA1 LRRC40 PTPRU ACVRL1 CYP46A1 LINC00310 CFB SLC38A1 MAST4 NUP210 SIK2 ALK TNS3 | 4.63e-03 | 1194 | 173 | 15 | EFO_0001645 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.78e-03 | 264 | 173 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | IGA glomerulonephritis | 4.82e-03 | 58 | 173 | 3 | EFO_0004194 | |
| Disease | late-onset myasthenia gravis | 4.92e-03 | 18 | 173 | 2 | EFO_1001490 | |
| Disease | Intellectual Disability | 5.04e-03 | 447 | 173 | 8 | C3714756 | |
| Disease | insulin resistance | 5.06e-03 | 59 | 173 | 3 | EFO_0002614 | |
| Disease | granulocyte percentage of myeloid white cells | 5.13e-03 | 268 | 173 | 6 | EFO_0007997 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 5.47e-03 | 19 | 173 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | Pancreatic carcinoma | 5.47e-03 | 19 | 173 | 2 | C0235974 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.47e-03 | 19 | 173 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | triglyceride measurement, body mass index | 5.47e-03 | 19 | 173 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | colorectal cancer, inflammatory bowel disease | 5.47e-03 | 19 | 173 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | reaction time measurement | 5.64e-03 | 658 | 173 | 10 | EFO_0008393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EITLQTNLPLQSPCC | 36 | P59036 | |
| TCNSVNLTILEPDQP | 196 | Q14264 | |
| VVLLPASQPEENVDC | 411 | A8K979 | |
| PLQDEQSVICLSNII | 1051 | Q96N23 | |
| EQQLPDNCVTLKVSP | 1126 | Q8WWN8 | |
| PELPCVENLNSIELN | 946 | Q8IVF6 | |
| LLETCPIQSPLQVFA | 4061 | Q9NR09 | |
| SLPNLVKNQLCPVIE | 191 | Q8TDL5 | |
| QECIILQPLNKCSPD | 556 | Q99708 | |
| PTDIISTPICGNQLV | 401 | Q9UKQ2 | |
| SQIAIVPQEPVLFNC | 1091 | Q2M3G0 | |
| NSVNLSCETQLPPER | 206 | Q96PJ5 | |
| EPCLAPSLEQQEQEL | 31 | P22455 | |
| LPLLTCLTQDQEFAP | 226 | Q8TCU4 | |
| IASDLPSPISLEQCQ | 2956 | Q8TCU4 | |
| QPEVVLQRQVCPDLL | 636 | Q8IYW2 | |
| VVCVDQQTPTIPNRL | 441 | P37023 | |
| NIVDPEDPRCVQLTL | 206 | Q8IUH2 | |
| ICLVDNIFPPVVNIT | 131 | P01909 | |
| LAICNTVVVSAPNQP | 591 | Q9P241 | |
| QLQPTDALLCVANLP | 126 | Q8IY67 | |
| QLQPTDALLCITNVP | 136 | Q9HCJ3 | |
| SQLPQIQTDVVLPSC | 366 | Q8IUH3 | |
| EVAPPAVLENIQSNC | 386 | O60674 | |
| NIENQEIVTNPPDIC | 186 | P14316 | |
| CVQQLLASEPLIQES | 231 | Q0D2K2 | |
| TLVLQNNLIPKVCPE | 41 | Q6ZNQ3 | |
| LQLCLQQFPDIPESV | 486 | Q9H8H0 | |
| LIEESCPQLANSVQI | 81 | Q9UJX4 | |
| TCVPLPKEQLQTVQD | 1646 | Q01484 | |
| QPSDNCIFSVELQLP | 86 | O75106 | |
| PTTTCQQQKEELLPA | 611 | P00751 | |
| DINDNCPTLIEPVQT | 491 | Q14126 | |
| ENLFLQCPKPTLQIS | 246 | Q06416 | |
| SCPLLQQNKQVVPVS | 766 | Q8TEM1 | |
| NLIQNECSVPFVPVE | 131 | Q9H4D5 | |
| PFQSEDLILCQLTVP | 396 | Q8WUM0 | |
| LLQCQVSSDPPATII | 1116 | Q15746 | |
| LPLLNNNLEPCSVTI | 786 | Q8N9B5 | |
| LNLVPQVQSVQCSPE | 996 | Q96PY6 | |
| EIENNPTVQASDCPL | 81 | Q5TGJ6 | |
| QPESVSCILQEPKRN | 406 | O14920 | |
| TPLNLEIDPNAQCVK | 106 | P78386 | |
| IQSCSNIAVPAPCIL | 3421 | Q9UKN7 | |
| NNQLSEIPAELADCP | 211 | Q8N1G4 | |
| NVSEDCPQILPSTQI | 701 | Q9UIW2 | |
| AVTVSETQLLCEPPN | 1191 | O75051 | |
| ILNCVNPDNENSPEI | 1501 | O75051 | |
| VSLVNVLDCCPPQLT | 896 | Q13608 | |
| PLCNQQKDSIPSIQI | 361 | Q9NP56 | |
| NDVPPCISQLLDNEE | 541 | O95263 | |
| QILAEPECNIFSNIP | 391 | O76083 | |
| TCQNEITLQVPNPSE | 276 | Q96EV8 | |
| AINLLQSCLSPPESN | 346 | Q8TE67 | |
| LDQPVLEQRLEPSTC | 676 | Q9Y4W2 | |
| VALIQDCRLPPSQAE | 356 | Q6ZNW5 | |
| TVQAEPLIQDNPECL | 246 | Q8IXQ5 | |
| NVETVFQPILCPELQ | 436 | Q8WWY8 | |
| PLIINCLSSPNEETV | 101 | Q9H6L4 | |
| CRVLVEVLDTNDNPP | 331 | Q9UN67 | |
| ICDVLQEPEQFPLVQ | 41 | P29728 | |
| IPPDNANIIECIDNS | 616 | Q02413 | |
| CLLTDEVAILPAPQN | 26 | Q6UXL0 | |
| LCDNKIQSIPPQLSQ | 196 | Q96CX6 | |
| LCTVPEADQPVRLTQ | 121 | Q9UBH0 | |
| PESFPELQNLTCLSV | 121 | Q9BTT6 | |
| ENLFLQCPKPTLQQI | 246 | Q01860 | |
| QTLNSVTPPLDVEEC | 1181 | Q92729 | |
| EIHCTLLPALQENTP | 291 | Q9NZH0 | |
| AQPATLSQTIVPICL | 306 | P04070 | |
| VPPILALSCSNVDIN | 181 | Q8NH90 | |
| CTLLLQVVDVNDNPP | 331 | Q9NRJ7 | |
| FLEQPICSVQPIDLN | 61 | Q9H3D4 | |
| VVSRNLSPPNCTELQ | 626 | P38398 | |
| LITIEINPDCAAITQ | 136 | P21964 | |
| FLPLANLECSPNIET | 61 | O60353 | |
| LCPTQPERAQELLNE | 1861 | Q14674 | |
| IPSVNLVVAENEPCE | 146 | Q9NSI5 | |
| QETLVAACQLQIPEI | 121 | Q53GT1 | |
| PFPTQVEELLCNLNS | 1591 | Q8NF50 | |
| QLICKQQTPELEPAA | 66 | Q8IWX8 | |
| AIQCNDINPQEDLPL | 1721 | Q9H799 | |
| QEQATLKPLDPVLCT | 471 | Q9Y6A2 | |
| ALPQDLQPVCASQEA | 71 | Q16661 | |
| TVLDPNVLVTCNRPE | 91 | P98172 | |
| LDIQTPSICDNQEIL | 241 | Q68CZ6 | |
| PTDLSCVIRNIQQSP | 191 | Q8IZF7 | |
| KCNLSVINLDPEINP | 66 | P41182 | |
| IISATITPLCQDPQL | 606 | Q0VDD8 | |
| ITPLCQDPQLSIFID | 611 | Q0VDD8 | |
| CVPINLKTLIPNASN | 241 | P20794 | |
| CETQLSPQRPDVQLQ | 211 | Q96P31 | |
| LQSLDENVCDVPPLS | 1486 | O15021 | |
| EPIPQIVATDVCQFL | 116 | P49356 | |
| LQCVTQTLETPNLDE | 441 | Q9ULL0 | |
| SLELLQCNENLPSSP | 31 | O60381 | |
| NPICLSQAELNDLPV | 331 | P22680 | |
| ENDQLSNQVVVCLLP | 591 | Q9H583 | |
| LIPDLNQITECSDPV | 101 | Q9UJC3 | |
| QTLSTQTILENSPCP | 961 | Q8NDH2 | |
| ACQEILFDPQTTIPE | 66 | Q96DZ5 | |
| QLIPEQITTDITPEC | 506 | Q96AC1 | |
| DLIPEVPRQLVTNCT | 116 | P43250 | |
| ASLPLNESERNQEPC | 1406 | Q9C0D2 | |
| LCTPLPEEFLDQNVV | 86 | Q8IVF4 | |
| QDIVCLLQPILNENS | 2251 | Q9NZJ4 | |
| LPVTETVCLTPNEDQ | 1086 | Q08AD1 | |
| TVCLTPNEDQLNQPT | 1091 | Q08AD1 | |
| NAPQVLPQEAETCET | 601 | P19022 | |
| ITPSQCKERNLQDPV | 2621 | Q02224 | |
| VLLQPQVLCDKDQPS | 201 | Q5VW36 | |
| NPCTPNNVEVLETRS | 901 | P42702 | |
| DCNSNLLETIPPELA | 226 | Q9H9A6 | |
| ITQAQEELSPCLTPA | 596 | O75807 | |
| ECQPEQILMPINSQL | 1296 | Q5VU65 | |
| PSCEILDINDEQTLP | 481 | Q02241 | |
| TQEVLCQLKRDQPSP | 546 | Q8IWE5 | |
| DIQSPLLEQCESFIP | 296 | Q8N8U3 | |
| PVDITPDRLQLVCNA | 36 | Q9NVX2 | |
| RLQCVPNPELLQTED | 716 | Q08AM6 | |
| ECQQLLLDIPLQTPH | 1166 | Q7Z3J3 | |
| VPPEASIATLNQLCA | 646 | Q13671 | |
| CNISLFEDLPLQEPQ | 326 | Q9UM63 | |
| LREVQPVELPNCNLV | 31 | P27169 | |
| EALQDLENTCPLPAT | 276 | Q8WUG5 | |
| TSDLLQVPDDLPNVC | 1636 | Q5UIP0 | |
| PVTPVETILQRCNLE | 331 | Q9NVN8 | |
| NPVLQNIQADPTIVC | 426 | Q96BP3 | |
| QDALNQLEEPPLISC | 636 | O00291 | |
| VHCLVPDLLQINNNP | 271 | Q8WXH5 | |
| IPTNALCSEEQLQIP | 196 | Q96LK8 | |
| APQLQDLASSCPQEE | 636 | Q9H0K1 | |
| ALEAPSIQIQELCLN | 456 | Q6P3W7 | |
| LTSLPAVQAPVIQEC | 21 | Q96M29 | |
| LLSPICEVANNIEQN | 141 | Q16637 | |
| VLNDPVNVRINCIPE | 66 | P14410 | |
| TLPTLCLQTSEAEPQ | 3741 | Q9P2P6 | |
| SDLQSPLNPCVILSE | 756 | P42338 | |
| ENPSRICIVIEPAQL | 221 | Q68CZ2 | |
| STQPPDESCSQNLLI | 6 | Q15391 | |
| FVCAQLPNPVLESIS | 136 | Q9NZN3 | |
| NEPETNCNPSLLSII | 281 | Q9NRX5 | |
| QPVFEIPLSNVSQCT | 126 | Q08945 | |
| ITLDNCSNDLHQLPP | 1026 | Q8NFU7 | |
| CTQDPDVINTALPIE | 1386 | Q9UM73 | |
| QIDFVPVQPLSSPQC | 921 | Q8IWZ3 | |
| QLIVIASDETPCNPV | 391 | O75339 | |
| QTSECIKIQPTDIQP | 56 | P24278 | |
| DEQLCIPPLNSQTCL | 206 | O94966 | |
| EFVSLINCSSQPPLI | 516 | O95793 | |
| ELIQSVLQKLQDPCP | 501 | Q9NX95 | |
| CQLEKALPTPQAQQL | 156 | Q9BSI4 | |
| ASVQLQLCQDPAPSL | 196 | Q6ZTI6 | |
| VDLRTVTCNIPPQEI | 91 | Q8TAV4 | |
| VTCNIPPQEILTRDS | 96 | Q8TAV4 | |
| SNIQACLPLTFTPEE | 31 | Q6UX40 | |
| VVQDPLLCDLPIQVT | 11 | Q9BV90 | |
| SNVIPTCEPQSLVEN | 1671 | O60281 | |
| VPVVNNDISSPCEQI | 266 | O15014 | |
| NSAIQCLSNTPPLTE | 301 | Q9Y4E8 | |
| CLPDQQPIPTETFQV | 366 | O75326 | |
| PATDAQCQTLPLTVL | 31 | Q9Y6A9 | |
| QCPSVEVSFLPLIVN | 2626 | Q709C8 | |
| ANVVPVQRTCNLVTP | 181 | Q68DE3 | |
| DICIAFQETLPTLQP | 231 | Q8TE23 | |
| LVPQNNEKLQESPCI | 151 | Q8N2W9 | |
| QQLLPQQLPECKVDS | 1926 | Q9BYW2 | |
| LCQIVNDLSPEVPSN | 26 | Q0D2K0 | |
| CLPNVLLESEQSNPF | 596 | Q6IQ21 | |
| PQRVSSAEQCLLPIQ | 121 | Q0VFX4 | |
| KVTQPILQTALPCQI | 356 | Q9Y6X8 | |
| APQSQQLCTPEDLST | 636 | Q8N895 | |
| PPVQEILTSSENNEC | 281 | Q9H0M0 | |
| STLQEIPPDLVCDIN | 366 | O15050 | |
| TQLLVPPENCSARVQ | 516 | Q9Y4E6 | |
| QLPALPSQLDLCEQV | 396 | Q9NQE7 | |
| QQLPVTDPFTLCSDI | 556 | Q8NA31 | |
| SPCNPIVRQKESELQ | 641 | Q9H2Y7 | |
| FQIPCIVPELNSTIS | 241 | Q9H2H9 | |
| VPDISQPCQDISEAL | 1261 | Q6PFW1 | |
| PEVVTPLQLQCCQRL | 801 | Q6ZT98 | |
| PQTISVPIDDLCQFL | 436 | A8MPX8 | |
| SISPELQQQICDLLS | 241 | Q5JTD7 | |
| EQDILAPQTVQCPAQ | 1381 | O15069 |